Publications scientifiques en oncologie
Receptor-mediated chemotherapy using a new docetaxel-peptide conjugate for sortilin-positive triple-negative breast cancer [abstract].
2019
Demeule M, Charfi C, Currie J-C, et al.
80(4 suppl):P3-10-07. Proceedings of the 2019 San Antonio Breast Cancer Symposium.
Receptor-mediated chemotherapy using a new docetaxel-peptide conjugate for sortilin-positive triple-negative breast cancer.
2019
Demeule M, Charfi C, Currie J-C, et al.
Poster #993 presented at: San Antonio Breast Cancer Symposium; December 10-14, 2019; San Antonio, Texas, USA.
Increasing potency and safety of anticancer drugs through sortilin receptor-mediated cancer therapy: A new targeted approach for the treatment of ovarian cancer [abstract].
2019
J Clin Oncol.
Annabi B, Demeule M, Currie J-C, et al.
37(suppl):e17068. Proceedings of the Annual Meeting of the American Society for Clinical Oncology.
New docetaxel-peptide conjugate for the treatment of sortilin-positive triple-negative breast cancer [abstract].
2019
J Clin Oncol.
Demeule M, Annabi B, Currie J-C, et al.
37(suppl):e12556. Proceedings of the Annual Meeting of the American Society for Clinical Oncology.
Increasing penetration of anticancer drugs through Sortilin receptor-mediated cancer therapy: A new targeted and personalized approach in the treatment of ovarian cancer [abstract].
2017
Cancer Res.
Demeule M, Currie J-C, Larocque A, et al.
77(13 suppl):5146. Proceedings of the Annual Meeting of the American Association for Cancer Research 2017.